For any enquiry about our products, please phone us on +34 917 991 564 |info@finabiotech.es

Grid

Grid2019-01-18T15:46:35+01:00

FINA BIOTECH has recently obtained a grant from the OEPM (Spanish Patent and Trademark Office) for the promotion of international patent applications and utility models

By |agosto 25th, 2019|Categories: Finabiotech News|

Fina Biotech has obtained for the 12th consecutive year the grant from the OEPM (Spanish Patent and Trademark Office) for the promotion of international patent applications and utility models. With this grant, the OEPM recognizes [...]

Comentarios desactivados en FINA BIOTECH has recently obtained a grant from the OEPM (Spanish Patent and Trademark Office) for the promotion of international patent applications and utility models

Press-release: FINA BIOTECH has successfully validated the results of its bladder cancer diagnostic test in Chinese population

By |marzo 30th, 2019|Categories: Finabiotech News|

Fina Biotech has successfully validated the previously reported European study results of its bladder cancer diagnostic test in an independent Asian cohort. The prospective blinded study was carried out at the Fudan University Shanghai Cancer [...]

Comentarios desactivados en Press-release: FINA BIOTECH has successfully validated the results of its bladder cancer diagnostic test in Chinese population

Press-release: FINA BIOTECH announces its merger by absorption with BIOFINA DIAGNOSTICS

By |octubre 4th, 2018|Categories: Finabiotech News|

FINA BIOTECH (acquiring company) has recently completed its merger by absorption with BIOFINA DIAGNOSTICS (acquired company). Both companies took the decision in their respective shareholders´ meeting last June. The combination amplifies FINA BIOTECH´s expertise and [...]

Comentarios desactivados en Press-release: FINA BIOTECH announces its merger by absorption with BIOFINA DIAGNOSTICS

Press release – Fina Biotech reinforces its IP portfolio with a new patent in the USA

By |mayo 25th, 2018|Categories: Finabiotech News|

Fina Biotech announces that the United States Patent and Trademark Office (USPTO) has recently granted patent number 9,902,998 to protect a ´NON-INVASIVE DIAGNOSTIC METHOD FOR DIAGNOSING BLADDER CANCER´. The patent will be in force until [...]

Press release – Biofina Diagnostics is awarded with a Seal of Excellence by the European Commission

By |abril 10th, 2017|Categories: Finabiotech News|

Biofina Diagnostics S.L has been recently awarded with a Seal of Excellence by the European Commission following the presentation of its project proposal UROBEST ´UROthelial carcinoma Biomarker based diagnostic tEST´ Submitted under the Horizon 2020’s [...]

Recent presentations of UROBEST in international meetings

By |marzo 10th, 2017|Categories: Finabiotech News|

Press release March 8th, 2017 RECENT PRESENTATIONS OF UROBEST IN INTERNATIONAL MEETINGS UROBEST has been presented in both the 23rd Meeting of the EAU Section of Urological Research (ESUR) held in October 20th- 22nd, 2016 [...]

Biofina Diagnostics S.L. attends BIOSPAIN 2016

By |octubre 5th, 2016|Categories: Finabiotech News|

Biofina Diagnostics S.L. has recently attended BIOSPAIN2016, the 8th edition of the International Meeting on Biotechnology which took place in Bilbao (Spain) from the 28th to 30th of September. BIOSPAIN is the largest European biotech [...]

Biofina Diagnostics S.L has recently attended the 111th American Urological Association’s Annual Meeting (AUA2016) held in San Diego, California, from the 6th until the 10th of May.

By |mayo 18th, 2016|Categories: Finabiotech News|

Press release May 18th, 2016 Biofina Diagnostics S.L has recently attended the 111th American Urological Association's Annual Meeting (AUA2016) held in San Diego, California, from the 6th until the 10th of May. Dr. Mengual has presented [...]

Go to Top